Cannabinoids have the potential to transform the treatment of human disease across a wide range of therapeutic applications by targeting the endocannabinoid system. Yet, the broad application of cannabinoids is currently limited by imprecise dosing, a lack of standardization, inconsistency, and the limitations of today’s available delivery technologies.